Race and ethnicity are associated with health disparities among individuals with psoriasis.
Racial and/or ethnic minoritized individuals are 112% more likely to live with undiagnosed psoriasis than White individuals.
Compared to White individuals, individuals with skin of color wait 3 times longer to receive a diagnosis of psoriasis and are 3 times more likely to have a skin biopsy to confer a diagnosis.
Racial and/or ethnic minoritized individuals are 40% less likely to report having seen a dermatologist for psoriasis and have fewer ambulatory visits for psoriasis compared to Whites.
Compared to Whites, Asians, Hispanics, and Blacks experience higher rates of severe psoriasis.
Despite having more severe disease, use of biologic therapy is lower among Blacks compared to Whites.
This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.